These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. New and developing non-adrenoreceptor small molecule drugs for the treatment of asthma. Thomson NC Expert Opin Pharmacother; 2017 Feb; 18(3):283-293. PubMed ID: 28099820 [TBL] [Abstract][Full Text] [Related]
29. Adapting clinical trial design to maintain meaningful outcomes during a multicenter asthma trial in the precision medicine era. Sorkness CA; King TS; Dyer AM; Chinchilli VM; Mauger DT; Krishnan JA; Blake K; Castro M; Covar R; Israel E; Kraft M; Lang JE; Lugogo N; Peters SP; Wechsler ME; Wenzel SE; Lazarus SC; Contemp Clin Trials; 2019 Feb; 77():98-103. PubMed ID: 30593883 [TBL] [Abstract][Full Text] [Related]
30. Effectiveness of drug treatment strategies to prevent asthma exacerbations and increase symptom-free days in asthmatic children: a network meta-analysis. Zhao Y; Han S; Shang J; Zhao X; Pu R; Shi L J Asthma; 2015 Oct; 52(8):846-57. PubMed ID: 26061910 [TBL] [Abstract][Full Text] [Related]
31. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma]. Korn S; Vogelmeier C; Buhl R Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216 [TBL] [Abstract][Full Text] [Related]
32. Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma. Chipps BE; Figliomeni M; Spector S Allergy Asthma Proc; 2012; 33(5):377-85. PubMed ID: 23026179 [TBL] [Abstract][Full Text] [Related]
33. The management of severe asthma in 2020. Côté A; Godbout K; Boulet LP Biochem Pharmacol; 2020 Sep; 179():114112. PubMed ID: 32598948 [TBL] [Abstract][Full Text] [Related]
34. Characteristics, phenotypes, mechanisms and management of severe asthma. Chung KF; Dixey P; Abubakar-Waziri H; Bhavsar P; Patel PH; Guo S; Ji Y Chin Med J (Engl); 2022 May; 135(10):1141-1155. PubMed ID: 35633594 [TBL] [Abstract][Full Text] [Related]
35. Severe asthma: advances in current management and future therapy. Barnes PJ J Allergy Clin Immunol; 2012 Jan; 129(1):48-59. PubMed ID: 22196524 [TBL] [Abstract][Full Text] [Related]
36. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Virchow JC; Prasse A; Naya I; Summerton L; Harris A Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):578-85. PubMed ID: 10934090 [TBL] [Abstract][Full Text] [Related]
37. [Current Asthma Treatment in Light of New Asthma Guidelines]. Lommatzsch M Dtsch Med Wochenschr; 2018 Jun; 143(11):806-810. PubMed ID: 29807381 [TBL] [Abstract][Full Text] [Related]
38. [Severe asthma in adults]. Weersink EJ; Braunstahl GJ; Roldaan AC Ned Tijdschr Geneeskd; 2013; 157(19):A6232. PubMed ID: 23657105 [TBL] [Abstract][Full Text] [Related]
39. Medications and Recent Patents for Status Asthmaticus in Children. Hon KLE; Leung AKC Recent Pat Inflamm Allergy Drug Discov; 2017; 11(1):12-21. PubMed ID: 28137226 [TBL] [Abstract][Full Text] [Related]
40. Precision medicine in asthma: linking phenotypes to targeted treatments. Chung KF Curr Opin Pulm Med; 2018 Jan; 24(1):4-10. PubMed ID: 29036018 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]